← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksGPCRRevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

GPCR logoStructure Therapeutics Inc. (GPCR) Revenue History

Annual and quarterly revenue from 2020 to 2025

TTM Revenue
$0
0
YoY Growth
-
Latest Quarter
$0
Q4 2025
QoQ Growth
-

Compound Annual Growth Rate (CAGR)

3-Year-
5-Year-
10-Year-
Highest Annual Revenue$0 (0)
Highest Quarter$0 ()

Loading revenue history...

GPCR Revenue Growth

1-Year Growth
-
3-Year CAGR
-
5-Year CAGR
-
10-Year CAGR
-
TTM vs Prior Year-
Peak Annual Revenue$0 (0)

Download Historical Data

6 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

GPCR Revenue Analysis (2020–2025)

As of May 7, 2026, Structure Therapeutics Inc. (GPCR) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.

Looking at the longer-term picture, GPCR's historical revenue data shows various trends over time.

When compared to Healthcare sector peers including CHRS (-78.1% YoY), KYMR (-12.6% YoY), and ARWR (+43539.2% YoY). Compare GPCR vs CHRS →

GPCR Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
GPCR logoGPCRCurrent$0---
CHRS logoCHRS$42M-78.1%-38.4%-429.5%
KYMR logoKYMR$39M-12.6%+2.9%-891.3%
ARWR logoARWR$829M+43539.2%+56.6%11.9%
Best in groupLowest in group

GPCR Historical Revenue Data (2020–2025)

Showing 6 of 6 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$0-$-3,899,285-$-287,567,533-
2024$0-$0-$-158,228,000-
2023$0-$0-$-102,775,000-
2022$0-$0-$-52,561,000-
2021$0-$0-$-37,696,000-
2020$0-$-20,034-$-15,933,378-

See GPCR's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is GPCR Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare GPCR vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

GPCR — Frequently Asked Questions

Quick answers to the most common questions about buying GPCR stock.

Is GPCR's revenue growth accelerating or slowing?

GPCR TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.

What is GPCR's long-term revenue growth rate?

Structure Therapeutics Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.

How is GPCR's revenue distributed by segment?

GPCR reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2020-2025 are available for download. Segment mix reveals concentration and diversification trends.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

GPCR Revenue Over Time (2020–2025)